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1 MITIGATE Antimicrobial Stewardship Toolkit 
About this guide 
 
This guide is written for healthcare providers and administrators interested in designing quality 
improvement programs in antimicrobial stewardship. 
This guide outlines how facilities can implement individualized, effective, and practical antimicrobial 
stewardship programs in acute care (emergency department and urgent care) settings.     
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Introduction
 
 
CDC Core Elements for Outpatient 
Antibiotic Stewardship Programs 
Commitment: 
Demonstrate dedication 
to and accountability Ifor optimizing antibiotic 
prescribing and patient 
safety.
Action for policy & 
practice:
mplement at least one 
policy or practice to 
improve antibiotic 
prescribing, assess 
whether it is working, 
and modify as needed.
Tracking & reporting:
Monitor antibiotic 
prescribing practices 
and offer regular 
feedback to clinicians, 
or have clinicians assess 
their own antibiotic 
prescribing practices 
themselves.
Education & expertise:
Provide educational 
resources to clinicians 
and patients on 
antibiotic prescribing, 
and ensure access to 
needed expertise on 
optimizing antibiotic 
prescribing.
Inappropriate antibiotic use is a major public 
health concern. Excessive exposure to antibiotics 
results in the emergence and spread of drug-
resistant bacteria, potentially avoidable adverse 
drug reactions, and increased healthcare 
utilization and cost. According to the Centers for 
Disease Control and 
Prevention, antibiotic-
resistant bacteria cause 
two million illnesses and
approximately 23,000 
deaths each year in the 
United States.1National 
professional 
organizations including 
the Infectious Diseases 
Society of America 
(IDSA) and the 
Society for Healthcare 
Epidemiology (SHEA), 
and an Executive Order 
from the President of the 
United States, 
recommend expansion of 
antimicrobial stewardship
to these ambulatory care settings. 
In 2016, CDC released the Core Elements of 
Outpatient Antibiotic Stewardship which provide a 
recommended framework for implementing 
stewardship in these outpatient settings, including 
urgent care and emergency departments.19 The 
goal of antimicrobial stewardship is to 
effectively promote judicious antibiotic use in 
all healthcare settings.  
Each year, 10 million antibiotic prescriptions are 
written from the emergency department (ED). 
Unnecessary antibiotics are frequently prescribed 
for known viral infections, including 75% of 
adults with acute bronchitis2,3 and 45% of 
children with viral URI.4 As annual ED visits 
across the U.S. continues to rise,5 strategies are 
desperately needed to reduce inappropriate 
antibiotic use, associated adverse events,6 and 
development of local resistance in acute care 
outpatient settings.7-9 
We know a “one size fits all” approach is not 
feasible for ED- and urgent care-based 
implementation of 
antimicrobial stewardship; 
effective stewardship 
strategies need to be 
adapted to these 
settings. Providers in 
settings like yours are 
faced with unique 
challenges to rational 
decision making 
such as frequent 
interruptions,10 
high-volume care, the 
need for rapid decisions 
with limited 
information, variation in 
staff over different 
shifts, and concerns with 
immediate patient 
satisfaction.11-14   While emergency 
providers understand the problem of antibiotic 
resistance, practice change is difficult.15,16 
The MITIGATE Tool Kit (A Multifaceted 
Intervention to Improve Prescribing for Acute 
Respiratory Infection for Adults and Children in 
Emergency Department and Urgent Care 
Settings) is a systematically adapted antibiotic 
stewardship program developed for use in 
emergency department and urgent care settings in 
collaboration with physicians, administrators, 
nurses, and patients. MITIGATE also includes 
specific strategies for pediatric settings. 
Implementation of this toolkit will meet the 
CDC’s Core Elements of Outpatient Antibiotic 
Stewardship, click for more detailed information. 
4 MITIGATE Antimicrobial Stewardship Toolkit 
Overview
The goal of MITIGATE is to provide a feasible 
and effective system for implementing 
antimicrobial stewardship and reducing 
inappropriate prescribing in emergency 
department (ED) and urgent care settings. Using 
materials from the CDC Be Antibiotics Aware 
campaign, strategies have been enhanced in 
collaboration with administrators and clinicians. 
This toolkit provides methods to individualize 
strategies to different settings. 
MITIGATE consists of six specific components: 
Provider 
Education
Patient 
Education
Provider 
Commitment-
Enhanced Patient 
Education
Program 
Champion
Department 
Feedback
Personalized 
Feedback
Provider Education: Clinicians learn about 
antibiotic resistance and alternative options for 
patient care through educational presentations, 
electronic reminders of Acute Respiratory 
Infection (ARI) guidelines, and Be Antibiotics 
Aware brochures.  
Patient Education: Patients learn about the need 
for judicious use of antibiotics through 
strategically placed CDC Be Antibiotics Aware 
posters, educational materials, and discharge 
handouts.  
Provider Commitment-Enhanced Patient 
Education: Personalized posters in exam rooms, 
including modified Be Antibiotics Aware content 
directed at patients, are enhanced with clinicians’ 
signed public commitment to antibiotic 
stewardship. Clinicians, nurses, and staff can also 
wear or use items, such as badge reels and pins, 
which encourage patients to ask about antibiotic 
stewardship.  
Program Champion: A designated champion 
(physician, other healthcare professional, and 
staff) at the site leads provider education and 
advocates for antimicrobial stewardship. 
Departmental Feedback: Each month the 
antibiotic prescribing practices for ARIs are 
aggregated from the electronic health record data 
and provided to departmental leadership. More 
details in Action Step 5. 
Personalized Feedback: Personalized monthly 
performance rankings are provided to each 
physician by email. Each physician receives the 
designation of being a “top performer” (top 
decile) or “not a top performer” for appropriate 
antibiotic prescribing for ARI. Designations are 
made by looking at performance at the site. More 
details in Action Step 5. 
In summary 
MITIGATE consists of simple strategies to 
engage patients and providers in 
understanding appropriate antibiotic 
prescribing. These strategies can be 
individualized to each site to ensure they fit 
within the culture and workflow of the 
organization. 
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Pre-Implementation Planning
Your How-To Preparation Guide 
We focus on “supply-side” interventions that target 
providers to change prescribing behavior—an approach 
well matched to the goal of encouraging uptake of 
effective evidence-based treatments in healthcare. You will 
learn about “nudges,” a behavioral science strategy focused 
on positive reinforcement and suggestions, which have the 
advantage of being designed to improve care decisions, 
without limiting the choices available to physicians.17 They 
are also scalable and do not require much extra time to 
improve quality of care.18 We extend proven approaches to 
the outpatient setting by obtaining stakeholder feedback to 
adapt current methods. We aim to achieve the greatest public health impact on antimicrobial use in ED and 
urgent care settings consistent with CDC Core Elements of Outpatient Antibiotic Stewardship: 
commitment, action for policy and practice, tracking and reporting, and education and expertise, using 
implementation tools found to be feasible in the ED and accepted by ED providers.  
A study worksheet found in the appendix will help guide you through this toolkit. Pause to review when 
you see this icon .
Pre-implementation Assessment: 
During the preparatory phase of the trial, it is important for key personnel at each location to work closely 
together in order to localize each of the intervention procedures to ensure they are consistent with local 
workflows, policies, and standards. Your team will develop a plan for implementing and monitoring each 
of the implementation steps. You will learn to refine standard operating procedures and share those with 
staff. You will also develop clinician enrollment procedures for electronic and in-person enrollment with 
clinical champions and departmental leads. You can consider risk analysis with a monitoring plan to 
ensure that interventions are delivered with fidelity to the original design and deviations are recorded (e.g. 
lapse in feedback to departmental lead after management turnover).  
Preparation for implementing your antibiotic stewardship program will encompass the following: 
1. Identify key stakeholders and potential champions
2. Conduct stakeholder interviews and engagement
3. Conduct surveys
4. Compile data
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STEP 1: IDENTIFY KEY STAKEHOLDERS AND POTENTIAL CHAMPIONS 
Emergency and urgent care healthcare professionals are ideally suited to lead antibiotic stewardship 
programs in ED and urgent care settings given their team-based approach to patient care, the nexus of 
emergency care settings between the community and hospital, and general willingness to take on new 
tasks and learn. Identifying key team members will help make implementation a success (see Figure 1). 
Figure 1: Key Personnel and Key Tasks 
Clinical Champion 
The "face" of the intervention. 
Lead the interventions, serve as a 
resource for education, serve as 
liaison between the department and 
administration. 
Departmental Director 
Refine standard operating 
procedure and develop provider 
enrollment procedures (electronic, 
in-person). 
Nursing Leadership 
Guide clinical workflow review 
and refine standard operating 
procedure. 
Institutional Leadership (Chief 
Quality Officer or Chief Medical 
Officer) 
Sponsor the program and provide 
institutional administrative and 
programmatic support for 
implementation and evaluation. 
Information Technology Specialist 
Data extraction for performance 
reports. 
Framework for regular personalized 
feedback for peer comparison. 
Program Manager 
Develop monitoring plan to ensure 
interventions are delivered with 
fidelity, and record modifications. 
a. Engage Leadership: While the MITIGATE program has been developed to be as simple as
possible, the program does require time and effort. Broader support from the institution beyond the
ED is necessary, and time should be spent at the outset obtaining buy-in from department and
institution leaders to ensure antibiotic stewardship, as a quality improvement initiative, is aligned
with institutional operational goals. MITIGATE can be framed as a patient safety and quality
improvement initiative that meets the CDC Core Elements of Antibiotic Stewardship, but will also
benefit patients, improve communication, and contribute to avoidance of healthcare associated
infections such as Clostridium difficile. In this way, the leadership can help individualize the
program and help identify any potential challenges. For example, external factors such as EHR
upgrades and staffing may slow down the process despite clinical importance, and leadership will
be aware of these issues and may help support antibiotic stewardship through the process.
b. Identify Program Champion: Characteristics of a good program champion include enthusiasm for
patient safety and quality improvement, being trusted by leadership and colleagues, the ability to
engage a variety of stakeholders, and having an understanding of data analysis and reporting.
Protected effort of at least four hours a week is essential for the program champion and
demonstrates institutional commitment to antibiotic stewardship.
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c. Information Technology (IT) Support: Determination of who will assist with report writing, data 
collection, and program evaluation should be established ahead of time. For intervention-heavy 
programs, several weeks should be spent in the planning of the program. This could be a report 
writer or data analyst housed in the department/practice, quality division, or in pharmacy services. 
d. Nursing Leadership: Inclusion of nurse stakeholders is critical to program success. Nurses interact 
directly with patients, provide education, and understand workflow processes from patient triage to 
discharge. 
e. Program Manager: If additional resources are available, a program manager can facilitate many of 
the programmatic tasks to ensure success. The program manager has a vital role in assisting the 
champion with coordination of stakeholder meetings, data preparation and distribution of feedback, 
and program evaluation. 
Take a moment 
 
STEP 2: CONDUCT INTERVIEWS 
Key Stakeholder Interviews: The local champion is best suited to conduct these semi-structured 
interviews; they will survey a range of people (e.g. emergency medicine administrators, various clinical 
providers, nurses, and support staff) with knowledge of workflow and practices at the site. The pre-
implementation interviews (see Appendix) include an assessment of current knowledge, attitudes and 
beliefs on antibiotic prescribing, resources currently available to help make prescribing decisions, and 
barriers and facilitators to antibiotic stewardship at the site. Vignettes can be included to facilitate 
discussion. At this time, physicians, nurses, and administrator stakeholders can also review a wide range 
of educational materials (pamphlets, info sheets, posters, etc.) and provide feedback on usability and 
desirability for the site. 
If possible, interviews should be audio recorded and comprehensive notes collected for later review and 
comparison. Pre-implementation interviews are shared in Appendix. 
Sample educational materials can be found here: https://www.cdc.gov/antibiotic-use/ 
Take a moment 
 
STEP 3: CONDUCT SURVEY 
Participant Knowledge and Use Survey: Diverse backgrounds among clinicians are frequent, therefore an 
assessment of all clinicians in the ED and urgent care system is important for understanding how to adapt 
the intervention. Because interviewing everyone is not feasible, clinicians of all types (physicians and 
advanced practice providers) can complete a survey prior to implementation of the intervention, and after 
the intervention has been implemented (at least six months). Here, providers will be asked about attitudes 
toward antibiotic use and stewardship programs, as well as knowledge of appropriate antibiotic use and 
education. Additionally, to test the success of the program and obtain feedback about any needed 
adaptations, the survey can be re-administered. In the follow-up survey, providers will be asked about the 
stewardship intervention, their opinions of the program, specific components of the program, and barriers 
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and benefits of the intervention. Data can be used to make needed changes to ensure ongoing success. See 
Appendix for ongoing surveys you can use directly with your team. 
Facilities and staff with access to platforms such as REDCap or Qualtrics can use them to create and 
disseminate the survey. Alternatively, Survey Monkey can be used for sites with limited resources to 
administer and collect responses before and after implementation.  
Take a moment 
STEP 4: COMPILE DATA TO DETERMINE INTERVENTION STEPS 
Based on the pre-implementation interviews, practice champions can begin selection of appropriate patient 
and clinician educational materials. However, other important factors to consider are: site size, site layout, 
feasibility, acceptability, and department policies. Gather all this data to help determine feasibility and 
acceptability of stewardship materials and methods. Key information to obtain at baseline includes: 
stakeholder demographics (what types of clinicians need to be reached out to, experienced vs new 
practitioners, level of education and training), baseline attitudes towards antibiotic prescribing, knowledge 
of antibiotic use and guidelines, preferences regarding commitment tools, preferences regarding patient 
and clinician educational tools, and identified gaps. In the case of limited programmatic support, the 
minimum amount of information to obtain should be preferences regarding commitment and educational 
tools, and existing gaps in supporting antibiotic stewardship efforts. 
Optional: Sites that wish to measure success over time require IT support staff can develop initial and 
subsequent monthly reports capturing prescribing rates of providers. A detailed list of conditions and 
exclusions can be found in the Appendix. 
Take a moment 
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IMPLEMENTATION PREPARATION ACTION 
STEPS 
Specific interventions for each site will depend upon available resources and the pre-implementation 
assessment. See Table 1 for a summary of potential intervention components for local ED and urgent care 
site adaption. 
Table 1. Intervention Components 
Component Definition 
Provider Education 
Patient Education 
Provider Commitment 
Departmental Feedback 
Provider Feedback and 
Education 
Peer Comparison using 
Personalized Audit and 
Feedback 
Educational presentations, smartphone  apps, CDC Be Antibiotics Aware 
brochures. 
CDC Be Antibiotics Aware posters in waiting rooms, Choosing Wisely brochures, 
discharge handouts. 
Physician-worn “flair” (pens, pins, badge reels, etc.) that are thematically 
consistent with the CDC Be Antibiotics Aware posters and brochures. 
Monthly aggregate of antibiotic prescribing practices for ARI from electronic 
health record data provided to departmental leadership. 
Case-based educational rounds with a stewardship consulting service (if available). 
Alternatively, ED pharmacists can provide consultations for patient-related issues. 
Personalized monthly performance rankings with each physician receiving a 
designation of being a “top performer” (top decile) or “not a top performer” for 
18*appropriate antibiotic Rx for ARI delivered by email.  
*Peer comparison will be distinct from traditional audit-and-feedback interventions in its comparison with top-performing peers
instead of group performance, and its validated benefit of delivery of positive reinforcement to top performers. Norms will be
computed within each setting within each site.
1. SELECTION OF PATIENT AND CLINICIAN EDUCATIONAL MATERIALS: Choose your
information! 
Given that clinicians know when antibiotics are not indicated, 
strategies to help nudge providers to making the right decision 
may be helpful. These include tools and materials to 
communicate risks versus benefits of antibiotics, including the 
possibility of patient harm from inappropriate use. Nudges can be 
selected based on stakeholder input for likelihood of uptake. For 
example, the CDC Viral Prescription Pad is an innovative tool to 
provide patients with reasons why an antibiotic prescription is not 
needed, as well as suggested alternative treatments (see Figure 6). 
However, sites that heavily rely on electronic discharge 
instructions may have lower uptake of this tool or may consider 
implementing the tool as a smart phrase or custom discharge 
instruction. Additional examples of patient and provider education materials are referenced below. 
Evidence suggests that written and verbal communication messages that educate patients on the difference 
between viral and bacterial infections may not be as effective.   
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Center for Disease Control and 
Prevention - Be Antibiotics Aware: 
Be Antibiotics Aware features targeted 
messaging and relevant materials to meet 
the increasing demand for resources and 
information about antibiotics. The 
new initiative provides resources to help 
improve antibiotic prescribing among 
healthcare professionals, focusing on 
prescribing antibiotics only when needed, and at the right dose for the right duration and at the right time. 
Be Antibiotics Aware features a number of resources including social media messages, communication 
tools, graphics, posters geared at patients, and videos to help healthcare professionals (in both outpatient 
and inpatient settings) educate patients and families about antibiotic use and risks for potential side effects.  
For more information visit: www.cdc.gov/antibiotic-use 
U.S. Antibiotic Awareness Week 
U.S. Antibiotic Awareness Week is an annual 
one-week observance to raise awareness of the 
threat of antibiotic resistance and the 
importance of appropriate antibiotic 
prescribing and use. The observance is a key 
component of CDC’s efforts to improve 
antibiotic stewardship in communities, in 
healthcare facilities, and on the farm in 
collaboration with state-based programs, 
nonprofit partners, and for-profit partners. 
Champions can take advantage of the 
resources provided by the CDC during this 
week to send out additional messaging via 
social media, and to hold activities centered 
around antibiotic stewardship such as grand rounds focused on stewardship, celebratory activities around 
accomplishments, and community engagement activities. 
Additional information: https://www.cdc.gov/antibiotic-use/week/overview.html 
Symptom Relief for Viral Respiratory Infections 
Since viral respiratory infections are non-responsive to antibiotics, the focus of treatment for these patients 
should be on symptom relief. The Centers for Diseases Control and Prevention has published suggested 
treatments for common complaints related to viral respiratory infections, such as rhinorrhea and 
congestion, sore throat, and cough (Table 2). It is important to note that over-the-counter (OTC) cough 
and cold medicines are NOT recommended for children under the age four years and are associated 
with substantial side effects. For children over four years of age, consultation with a health professional is 
recommended before OTC cough and cold medications are administered. Furthermore, patients and 
parents who choose to administer these OTC medications should be counseled that they are not curative 
for viral respiratory infections and should be advised regarding potential side effects.  
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Additional information:  
https://www.cdc.gov/antibiotic-use/community/for-patients/symptom-relief.html 
Table 2. Suggested Treatments 
Symptom Relief Treatment Options 
Rest and plenty of fluids 
Clean humidifier or cool mist vaporizer 
Acetaminophen, ibuprofen, or naproxen to relieve pain or fever 
Saline nasal spray or drops 
Gargle with salt water and eat popsicles for sore throat 
Decongestant to help relieve nasal symptoms 
Non-medicated lozenges (do not give lozenges to young children) 
Honey for cough (if your child is at least one year old) 
2. Clinician Commitment: Choose your nudges!
Research suggests that behavioral nudges including public commitment and peer comparisons reduce 
inappropriate prescribing in primary care, ED, and urgent care settings. Physician commitment is an 
evidence-based strategy for antibiotic stewardship in primary care settings. For example, signing a 
commitment log (Figure 2) indicates a personal commitment and accountability to appropriate prescribing 
and can be made public in department staff areas. Providing options for visible commitment in the 
emergency department or urgent care clinical areas may increase acceptability. For example, the use of 
badge reels or pins with a logo for the campaign serve as a reminder to clinicians and to patients about the 
commitment to avoid inappropriate antibiotic prescribing and avoidance of patient harm (Figure 5).  
Posters can be signed by clinicians to remind both patients and providers of the site’s commitment to 
appropriately prescribe (Figure 4). 
In some cases, providers may be reluctant to put their signature on posters for fear patients may use their 
signature. Most providers are receptive to either signing the posters or wearing the flair, however some are 
not interested in wearing pins or badge reels due to having their own or feeling it is an additional burden. 
Thus, having multiple options allows the public commitment to be personalized based on provider choice. 
Your pre-implementation survey will help you determine comfort level with different options. 
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Figure 2: Sample Log 
Figure 3: Sample options for commitment logo and flair 
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3. Posting of Clinical Provider Commitment to Antibiotic Stewardship: Share your
antibiotic knowledge!
Once you have chosen your educational materials and methods of sharing provider commitment, it is time 
to choose ways to share the information. For example, commitment letters that can be given to patients or 
posted in waiting rooms, clinician workstations, or patient care areas. Placement and delivery of materials 
to patients and providers should be determined with clinician and administrator stakeholders based on 
survey and/or interview results. Be sure to include your facility and maintenance teams in the discussion, 
as specific sites may require institutional approval to post materials in patient care areas (see below). 
Delivery will depend on site setup and configuration. Potential venues for patient education include 
posters and handouts in waiting room areas or at triage locations. Given the unique challenges of 
emergency departments and urgent care centers who are faced with rapid patient turnover, crowding, and 
multiple providers with potentially different levels of training working in shift-based formats, these posters 
may be placed in areas that are visible to both patients and clinicians. External factors, such as janitorial 
cleanup of areas, can keep posters from staying up, and supporting staff should routinely check materials 
during early stages. If possible, laminating and having different sized commitment letters can help reduce 
loss and make them noticeable. Additional physician and advanced care practitioner commitment such as 
signing a commitment log and wearing visible flair are alternative strategies.  
A note about facility flair and materials: 
When selecting flair and education materials, it is very important to take into account the local guidelines 
that govern each ED and urgent care setting. Consulting with local ED and UC administrations, including 
medical or operational directors, plant operations, or departmental nursing and business managers will 
save time and guide the selection of materials that are allowed to be used. This key step will also aid in the 
process of selecting areas that are “off limits,” but more importantly bring to light what and how materials 
can be placed in the different areas of a facility. 
4. Launching the program: 
Selecting a good start date can have some profound effects on the initial success of the program. It is 
important to select a date or dates where this project can have the direct attention of providers. At least two 
months prior to the planned start date, make a decision about your commitment and educational materials. 
These should be ordered at least four weeks prior to your target start date so that you can work with your 
stakeholders to determine best placement, how to reach and engage clinicians, and provide sufficient time 
for signing and printing of commitment letters and posters. If possible, during the weeks leading up to the 
launch date, the local champion can bring awareness to the project via presentations at staff meetings or by 
holding education sessions. A simple email sent to all participating providers can be an excellent way to 
answer any last-minute questions. See tips below. 
Launch Do’s and Don’ts 
Do send out announcement email letting staff know 
when program will be starting 
Don’t pick a week where staff might be out 
(conferences, retreats, etc.) 
Do bring awareness to the program by presentations or 
holding information sessions 
Don’t start on a weekend 
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Do have extra flair and materials Don’t begin activities without prior announcement and 
engagement of stakeholders 
Figure 4: Sample Commitment Letter 
Figure 5: Examples of distributed material from Previous CDC Get Smart Campaign 
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Figure 6: CDC Viral Prescription Pad  
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5. DEVELOP PROCESSES FOR DATA EXTRACTION: Gather the data!
In order to provide feedback on prescribing to clinicians and measure outcomes as accurately as possible, 
we developed a conservative approach (based on feedback from stakeholders) to increase validity and 
acceptance of individual feedback data for peer comparisons. The first step in developing a feedback 
process is figuring out how to access the data. 
Data Extraction 
Data extraction can be done with the IT team identified in the pre-implementation phase. This section talks 
about how to gather the data needed for the provider feedback. Patients with antibiotic-nonresponsive 
diagnoses include nonspecific upper respiratory infections, acute bronchitis, croup, bronchiolitis, and 
influenza without concomitant diagnostic codes to potentially support antibiotic prescribing (e.g. 
pneumonia, suppurative otitis media). Reported measures for emergency department and urgent care visits 
include antibiotic selection for visits with International Classification of Diseases, Tenth Revision [ICD-
10-CM] codes consistent with antibiotic-nonresponsive ARI diagnoses (see Figure 7), and ICD10 list 
(Table 3)—first sheet O=outcomes of interest and A=concomitant diagnosis that might necessitate 
antibiotics. Visits in which another diagnosis that typically requires antibiotics are excluded (i.e., an “A” 
code). A visit for an antibiotic-nonresponsive ARI (i.e., an “O” code) is eligible for outcome inclusion. We 
have developed a consensus-based list that provides a framework for specific inclusion and exclusion of 
diagnoses for eligible visits. This algorithm is best suited to sites with robust informatics support for 
reporting. This detailed list will hopefully satisfy concerns that reporting metrics may not address clinical 
conditions that could warrant antibiotics (such as a diagnosis of ARI in a patient who is immune 
suppressed and may be at risk for complications including bacterial infection).  
Alternative Measures 
Sites may choose to implement existing measures for practice site audit and feedback and/or pay for 
performance such as Healthcare Effectiveness Data and Information Set (HEDIS) measures or other pay-
for-performance measures if you do not have access to dedicated time from a report writer. Alternatives 
include existing data that is being reported for institutional quality measures, such as HEDIS or National 
Quality Forum Measures on appropriate antibiotic use for acute bronchitis. 
Figure 7. Suggested MITIGATE ICD10 Algorithm 
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DETAILED LIST OF CONDITIONS OF INTEREST AND EXCLUSIONS 
Pediatric Considerations 
Disease entities and causative pathogens often differ between adults and children. Three particular 
conditions—otitis media (OM), sinusitis, and conjunctivitis—have been attributed to both viral and 
bacterial etiologies, or sometimes even co-infection. For numerous reasons, including etiology, symptom 
management, return to school or daycare, and lack of accurate microbiologic data, antibiotics are 
frequently prescribed for these infections. For the purposes of creating a uniform approach in defining 
viral respiratory infections, this toolkit classifies these conditions as potentially antibiotic sensitive. 
Therefore, pediatric ED visits for one of these conditions are excluded as antibiotics may be appropriate. 
Current research and evolving literature should be considered when implementing the list below as part of 
this toolkit. 
0=outcome of interest; A=co-existing condition that may warrant antibiotic use; (*)=this code is inclusive 
of all codes contained within the higher level code (e.g., A00* means A00.00-A00.xx).  
Table 3. ICD-10 codes list 
A00* Cholera A 
A01* Typhoid A 
A02* Other GI Salmonella A 
A03* Shigella A 
A04* Other bacterial intestinal infections  A 
A05* Other bacterial foodborne infections A 
A06* Amebic infections A 
A07* Other protozoal intestinal infections A 
A09* Infectious gastroenteritis and colitis, unspecified A 
A15* TB A 
A17* TB A 
A18* TB A 
A19* TB A 
A2* Certain zoonotic bacterial diseases A 
A3* Bacterial diseases A 
A4* Bacterial diseases A 
A46* Erysipelas A 
A5* Bacteria STDs and syphilis A 
A64* Unspecified sexually transmitted disease A 
A65* Nonvenereal syphilis A 
A66* Yaws A 
A67* Pinta A 
A68* Relapsing Fevers A 
A69* Lyme and other spirochete infections A 
A7* Chlamydial and rickettsia disease A 
B5* Protozoal Diseases A 
B6* Other protozoal and spirochetes and worms A 
B7* Worms A 
B95* Strep, staph, enterococcus causing disease elsewhere classified A 
B96* Other bacterial agents causing disease elsewhere classified A 
G0* Meningitis, encephalitis, intracranial and spinal abscess A 
H00* Hordeolums and chalazion including eyelid abscess A 
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H05* Disorders of orbit A 
H10* Conjunctivitis A 
H15* Scleritis A 
H16* Keratitis A 
H20* Iridocyclitis A 
H440* Endophthalmitis A 
H441* Other endophthalmitis A 
H60* Otitis Externa A 
H610* Chondritis and perichondritis of ear A 
H65* Nonsuppurative otitis media O 
H66* Suppurative and unspecified otitis media A 
H67* OM in diseases classified elsewhere A 
H70* Mastoiditis A 
H73* Myringitis and other tympanic membrane disorder A 
H75* Mastoiditis A 
I00* Rheumatic Fever A 
I01* Rheumatic Fever A 
I311* Infectious Pericarditis A 
I33* Endocarditis A 
I38* Endocarditis A 
J00* Acute Nasopharyngitis (Common Cold) O 
J01* Sinusitis A 
J02* Pharyngitis A 
J03* Tonsillitis A 
J040* Laryngitis O 
J041* Tracheitis A 
J042* Laryngotracheitis O 
J043* Supraglottitis O 
J050* Croup O 
J051* Epiglottitis A 
J06* Acute URI of multiple or unspecified sites O 
J09* Influenza O 
J10* Influenza due to other influenza virus O 
J11* Influenza due to unidentified influenza virus O 
J12* Viral pneumonia O 
J13* Streptococcus pneumonaie pneumonia A 
J14* H Flu pneumonia A 
J15* Bacterial Pneumonia NOS A 
J16* Bacterial due to other infections pneumonia  A 
J18* Pneumonia of unspecified location A 
J200* Bronchitis mycoplasma A 
J201* Bronchitis h flu A 
J202* Bronchitis strep A 
J203* Bronchitis coxsackievirus O 
J204* Bronchitis parainfluenza O 
J205* Bronchitis RSV O 
J206* Bronchitis rhinovirus O 
J207* Bronchitis echovirus O 
J208* Bronchitis other specified organisms O 
J209* Unspecified bronchitis O 
J21* Bronchiolitis O 
J22* Lower RTI unspecified O 
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J30* Vasomotor and allergic rhinitis O 
J31* Chronic rhinitis, nasopharyngitis, and pharyngitis O 
J32* Chronic sinusitis A 
J340* Nasal abscess A 
J36* Peritonsillar abscess A 
J390* Retropharyngeal abscess A 
J391* Other abscess of pharynx A 
J40* Bronchitis NOS O 
J41* Chronic bronchitis specified such as mucopurulent A 
J42* Chronic bronchitis NOS A 
J43* Emphysema A 
J44* COPD A 
J45* Asthma O 
J47* Bronchiectasis A 
J80* ARDS A 
J84* Interstitial lung disease A 
J85* Lung abscess A 
J86* Pyothorax A 
K02* Dental caries A 
K04* Diseases of pulp and periapical tissue A 
K05* Gingivitis and periodontal diseases A 
K112* Sialoadenitis A 
K113* Salivary abscess A 
K12* Stomatitis A 
K35* Acute appendicitis A 
K36* Other appendicitis A 
K37* Unspecified appendicitis A 
K38* Other diseases of appendix A 
K50* Crohn's A 
K51* Ulcerative colitis A 
K55* Vascular disorders of intestine A 
K57* Diverticular disease of intestine A 
K61* Abscess of anal and rectal regions A 
K63* Other diseases of intestine A 
K65* Peritonitis A 
K66* Peritoneum A 
K67* Infectious disorders of peritoneum A 
K68* Disorders of retroperitoneum A 
K750* Abscess of liver A 
K80* Cholelithiasis, some with complications A 
K81* Cholecystitis A 
K83* Other diseases of biliary tract A 
K85* Acute pancreatitis A 
K92* Other diseases of digestive system A 
K94* Complications of artificial openings of the digestive system A 
K95* Complications of bariatric procedures A 
L00* L00  Staphylococcal scalded skin syndrome A 
L01* L01  Impetigo A 
L02* L02  Cutaneous abscess, furuncle and carbuncle A 
L03* L03  Cellulitis and acute lymphangitis A 
L04* L04  Acute lymphadenitis A 
L05* L05  Pilonidal cyst and sinus A 
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L08* L08  Other local infections of skin and subcutaneous tissue A 
L10* L10  Pemphigus A 
L11* L11  Other acantholytic disorders A 
L12* L12  Pemphigoid A 
L13* L13  Other bullous disorders A 
L14* L14  Bullous disorders in diseases classified elsewhere A 
L40* L40  Psoriasis A 
L51* L51  Erythema multiforme A 
L52* L52  Erythema nodosum A 
L600* L600  Ingrowing nail A 
L70* L70  Acne A 
L73* L73  Other follicular disorders including hidradenitis suppurativa A 
L88* L88  Pyoderma gangrenosum A 
L89* L89  Pressure ulcer A 
L97* L97  Non-pressure chronic ulcer of lower limb, not elsewhere classified A 
M00* Bacterial arthritis A 
M01* Other infectious arthritis A 
M46* Vertebral/disc infections A 
M60* Myositis A 
M70* Soft tissue disorders related to overuse and pressure, including bursitis A 
M86* Osteomyelitis A 
N10* Acute Pyelonephritis A 
N12* Tubulointerstitial Nephritis NOS A 
N151* Perinephric abscess A 
N30* Cystitis A 
N34* Urethritis A 
N390* UTI NOS A 
N41* Prostatitis A 
N45* Epididymo-orchitis A 
N476* Balanoposthitis A 
N481* Balanitis A 
N49* Inflammatory disorders of male genitals NOS including Fournier’s' 
 
A 
N61* Mastitis and Breast Abscess A 
N7* Female GU infections A 
O23* Infections of the genitourinary system in pregnancy A 
O411* Infection of amniotic sac and membranes A 
085* Puerperal sepsis A 
O86*  Other puerperal infections A 
O91* Infections of breast associated with pregnancy, the puerperium and 
 
A 
O98* Maternal infectious and parasitic diseases classifiable elsewhere but 
      
A 
P36*  Bacterial sepsis of newborn A 
P37* Other congenital infectious diseases A 
P38* Omphalitis A 
P39* Other infections specific to the perinatal period A 
P77* Necrotizing Enterocolitis A 
R36* Urethral discharge A 
R7881* Bacteremia A 
R8271* Bacteriuria A 
S31* Open wound of abdomen, lower back, pelvis and external genitals A 
S41* Open wound of shoulder and upper arm A 
S51*  Open wound of elbow and forearm A 
S61* Open wound of wrist, hand and fingers A 
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S71* Open wound of hip or thigh A 
T802* Infections following infusion, transfusion and therapeutic injection A 
T826* Prosthetic cardiac valve infection A 
T827* Other cardiac device infection A 
T845* Infections of internal joint prosthesis A 
T846* Infection of external fixation A 
T847* Infection of other internal orthopedic device A 
T84* Complications of internal orthopedic prosthetic devices, implants and 
 
A 
T85* Complications of other internal prosthetic devices, implants and grafts A 
T87* Complications peculiar to reattachment and amputation A 
T88*  Other complications of surgical and medical care, not elsewhere 
 
A 
W53* Contact with rodent A 
W54* Contact with dog A 
W55* Contact with other mammals A 
W56* Contact with marine animal A 
W57* Bitten or stung by nonvenomous insect and other nonvenomous 
 
A 
W59* Reptile A 
W60* Contact with nonvenomous plant thorns and spines and sharp leaves A 
W61*  Birds A 
W62* Amphibians A 
Y28* Contact with sharp object, undetermined intent A 
Y83* Surgical operation and other surgical procedures as the cause of 
          
         
A 
Z11* Encounter for screening for infectious and parasitic diseases A 
Z20* Contact with and (suspected) exposure to communicable diseases A 
Z21* Asymptomatic human immunodeficiency virus (HIV) infection status A 
Z22* Carrier of infectious disease A 
 
Data Extraction for Peer Comparisons 
In the peer comparison intervention, each provider’s individual performance is calculated as the 
percentage of encounters for non-antibiotic appropriate ARIs (i.e., “O” visits) listed in Table 1 for which 
the provider prescribed an oral antibiotic. Encounters occurring with patients who had certain 
comorbidities or other diagnosed bacterial infections (i.e., “A” visits) are excluded from the calculation. If 
the provider had more than 20 qualifying ARI encounters in the past 30 days, all these encounters were 
included in the calculation. Otherwise, the most recent 20 qualifying ARI encounters were included if they 
occurred in the past five months. If fewer than 20 occurred in the past five months, only encounters in the 
past five months are included and the provider is excluded from percentile rank calculations. 
5. STRATEGIES FOR REPORTING AND FEEDBACK: Share the data!  
Departmental Feedback 
Providing feedback to the department allows you to share information with your leadership and local team 
about the success of you antibiotic stewardship program. A monthly aggregate email to the departmental 
leadership summarizes antibiotic prescribing practices for ARI from electronic health record data. This 
includes total qualifying ARI visits evaluated by the department, as well as total and percentage of ARI 
visits with antibiotics prescribed. Over time, this data can also be used to help you decide if changes need 
to be made to your antibiotic stewardship program. 
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 Sample 1 Feedback email templates 
Peer Comparison (PC) 
 
MITIGATE is also an email-based intervention. Giving feedback to clinicians helps them monitor their 
own behavior and make changes based on their real prescribing habits. Before beginning the intervention, 
clinicians receive an email (see Sample 1) letting them know what to expect from the peer comparison 
emails and answering some frequently asked questions. Then, each month, using EHR data within each 
region about inappropriate prescription rates, clinicians are ranked from highest to lowest (see data 
extraction section). Rankings are typically only shared with the program team and administration, however 
sites may choose to share rankings with all clinicians. Clinicians with the lowest inappropriate prescribing 
rates (the top-performing 10th percentile) will be informed that they are a “top performer” in a 
congratulatory email. The remaining clinicians will be told that they are “not a top performer” by email. 
Emails will include the number and proportion of inappropriate antibiotic prescriptions written for a month 
for non-antibiotic-appropriate ARI cases and the proportion written by Top Performers. It is important to 
be specific in the language used for provider feedback, as this intervention refers specifically to antibiotic 
prescribing for likely viral respiratory infections, not appropriateness of prescribing for other known 
bacterial targets for antimicrobial stewardship (e.g. community-acquired pneumonia, urinary tract 
infection). See Samples 2 and 3 for sample language.  
 
Sample 2 Feedback email templates: 
 
 
 
Sample 3 Feedback email templates: 
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In some cases, clinicians might have a strong emotional reaction to the PC feedback. Those who are 
reacting may be over identifying with the label top performer and are preoccupied that they have not 
achieved this designation. They are unable to step away so that they can determine more clearly how to 
improve their practice. Or, even to see that they are very close to being a top performer given their score. 
Additionally, complaints about this feedback from colleagues can be distressing to the physician or staff 
champion. 
The FAQs below can be used to alleviate some of these emotions. It’s also important to help clinicians 
separate their emotions from the actions they need to take. For example, one could ask them to note or 
label how they reacted to the feedback (perhaps under the guise of QI. Getting feedback made me feel 
“frustrated,” “challenged,” “annoyed”). Noting or labeling will require them to distance themselves from 
their emotions in order to evaluate them. Then, once the emotion is no longer predominant, the individual 
can be asked to reflect on how to improve performance.  
Other potential phrases to address provider concerns include: 
“The feedback you receive is rooted in concern for the well-being of others. We provide frank and honest 
assessments of performance so as not to be evasive or to register this concern only on a very superficial 
level to clinicians” and “the purpose is not to offend, but to bring everyone closer to using a consistent 
approach to guidelines.” 
Depending on your site, the FAQs and feedback should be adjusted depending on the results and 
methods.      
See template and FAQ below: 
Dear [Organization Name] Provider, 
  
  
You will be receiving performance feedback e-mails as part of your participation in the behavioral economics study. 
In these e-mails, you will encounter the phrase “top performer.” In this context, "top performer” only refers to 
antibiotic prescribing for acute respiratory infections for which antibiotics are not indicated. The "top performers" 
among you have an inappropriate antibiotic prescribing rate of [Top Performer Rate]. These e-mails will also include 
the following responses to Frequently Asked Questions: 
• How many “top performers” can there be? 
Top performer status is achievable by everyone. We do not limit the number of top performers. For those of 
you who receive the "not top performer" emails, the bar may seem high, but many of your colleagues are 
reaching it. 
• How can I achieve top performance?  
The best way to improve clinical performance is to review the guidelines for antibiotic prescribing for acute 
respiratory infections and be faithful to them with future patients. If you do this consistently, you will achieve 
top performance. 
• Which patients are you including?  
We only include patients with diagnoses for which antibiotics are not indicated: non-specific upper 
respiratory infections, acute bronchitis, and influenza. 
• Which patients are excluded?  
We exclude patients with chronic lung disease, certain other medical conditions (e.g., immunosuppression), 
and any other concomitant infectious diagnosis. 
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• I have changed my prescribing, how soon will I see a change?  
Don't expect an instant change, but it will happen. There is at least a one-month delay in the data. Roughly 
speaking, we are looking at your most recent 20 applicable visits within the prior five months. If you do not 
see a lot of acute respiratory infection patients, your "top performer" email could take a few months to arrive. 
  
  
Sincerely, 
[Dr. Clinic Leader Name] 
6. OUTCOMES AND SUSTAINABILITY:  
The primary study outcome is the likelihood an antibiotic is prescribed in an antibiotic-nonresponsive 
acute respiratory infection (ARI) visit. This information may be obtained from electronic health record 
data as described in the process section above.   
Now that you have your program active, it is helpful to track these outcomes, select time points for the 
post-intervention survey, and collect and analyze survey and antibiotic prescribing data. You can check in 
regularly with your team regarding any changes that need to be made after the initial implementation. You 
can collect feedback through the survey as well as informally through discussions and feedback from 
clinician and administrative stakeholders. Data from the surveys can be used to demonstrate departmental 
change, and, if linked to individual clinicians, to show improvement in outlier physicians and to target 
academic detailing as well as knowledge deficits regarding antibiotic prescribing. You can gauge clinician 
experience with the antibiotic stewardship program through the ongoing survey results, and any areas of 
feedback or discord can be addressed with the stakeholder group. Changes in antibiotic prescribing 
performance can be calculated as a percentage of eligible visits that were included based on the algorithm 
for data extraction described above or existing measures such as HEDIS or NQF. This data can be 
displayed for feedback to the ED or urgent care practice using standard statistical process run charts (SPC) 
displaying performance over time similar to other quality improvement efforts. Periodic updates in the 
monthly newsletter or emails to staff can serve as positive reinforcement of successful efforts.   
Demonstration of success can be used to obtain institutional buy-in for programmatic and logistical 
support with ongoing report writing and expansion of programmatic efforts in antibiotic stewardship in 
order to lead to sustainability. These can also serve as the basis for partnerships with other community 
organizations and clinicians. 
Adherence Assessment 
In order to ensure that the study interventions are being reliably delivered, sites may create testing 
scripts that cover logical and coding variation in EHR-based interventions. Champions will need to 
designate personnel to conduct site evaluations regularly during the intervention to ensure that tests do 
not fail. For example, staff will verify that intervention materials are being used and posted and, if not, 
assess the barriers to implementation and facilitate their uptake. 
Throughout the course of the implementation, sites should consider monitoring “diagnostic drift” that 
may result in provider shifting diagnosis to avoid guideline conflicts that might trigger alerts or poor 
performance reports. Patient surveys to assess patient engagement and experience during the 
stewardship implementation may also be considered. 
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EVIDENCE FOR IMPLEMENTATION TOOLKIT
RESULTS OF COMPARATIVE ANALYSIS AND EVIDENCE BASED INTERVENTIONS 
FROM MITIGATE STUDY 
Kristina Shigyo MD, Larissa May MD MSPH MSHS, Aubyn Stahmer PhD, Kabir Yadav MDCM MS 
MSHS, for the MITIGATE Study Investigators Implementation of an Antimicrobial Stewardship 
Program for Acute Respiratory Infections in Acute Care Settings 
 
Background and Aims: Inappropriate antibiotic use within emergency department (ED) and urgent care 
center (UCC) settings is a major public health concern, yet few existing antimicrobial stewardship 
programs have been designed for application in these settings. As part of a project to adapt existing 
materials from the CDC’s outpatient Get Smart campaign to acute care settings, we report a pre-
-implementation workflow analysis of five acute care settings at two sites. The aim is to investigate the 
facilitators and barriers to incorporating an adapted Get Smart antimicrobial stewardship intervention to 
reduce inappropriate antibiotic prescribing for antibiotic—nonresponsive acute respiratory infections. 
 
 
 
Methods: Seventeen semi—structured interviews were conducted at Harbor—UCLA Medical Center 
and UC Davis Medical Center using purposeful sampling of physicians, registered nurses, and 
administrators in the adult ED, pediatric ED, and UCC. Interviews were recorded, transcribed, and 
analyzed independently by two researchers using NVivo 11. Grounded theory content analysis was 
performed for barriers and facilitators of implementation of antibiotic stewardship interventions in acute 
care settings, as well as any emergent themes. An anonymized survey assessing attitudes and beliefs of 
prescribing providers is also currently underway. 
Results: Preliminary analysis of the interviews suggests that facilitators to implementation include: 
incorporation of stewardship education into the triage process, provision of educational materials while 
patients wait for care, display of bilingual patient education materials within densely populated patient 
areas, education of residents and nurses, local guidelines for antibiotic use, and provision of viral 
prescription pads. Some notable barriers to implementation include: lack of coordinated communication 
amongst providers, maintaining staff and provider awareness of the program, difficulty of timing of the 
program interventions with the clinical workflow, and concern that lengthy wait times may increase 
antibiotic prescribing. 
Implications for practice/policy: This study can provide a framework for adaptation of existing 
antibiotic stewardship strategies to match the clinical workflow of acute care settings based on an 
analysis of the unique challenges inherent within these environments. It also provides a model of pre-
-implementation analysis for the development of antibiotic stewardship programs at new sites to 
account for, and adapt to, site--specific variables. 
 
Funding: This work was supported by CDC’s investments to combat antibiotic resistance under award 
number 200-2016-91939
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Figure 8. UC Davis distribution summary of selection of enhanced intervention materials for 
antimicrobial stewardship (1 site) 
 
Commitment log: 22 Badge reels: 13 
Total providers:  54 Total providers: 54 
    40.7% 24.1% 
Poster signatures: 33 Pins: 53 
Total providers: 54 Total providers: 54 
    
 
61.1% 98.1% 
Figure 9. Harbor Distribution summary of selection of enhanced intervention materials for 
antimicrobial stewardship (3 sites) 
Commitment log: 107 Badge reels: 61 
Total providers:  108 Total providers: 108 
    99.1% 56.5% 
Poster signatures: 49 Pins: 39 
Total providers: 108 Total providers: 108 
    
 
 
    
    
45.4% 36.1% 
Figure 10. Children’s Hospital Colorado Distribution summary of selection of enhanced intervention 
materials for antimicrobial stewardship (3 sites) 
Commitment log: 113 Badge reels: ~70 
Total providers:  145 Total providers: 145 
77.9% ~48% 
Poster signatures: 113 Pins: ~30 
Total providers: 145 Total providers: 145 
77.9% 21% 
 
 
 
 
 
 
 
 
 
 
  28 MITIGATE Antimicrobial Stewardship Toolkit  
 
EVIDENCE-BASED RESOURCES AND 
REFERENCES 
1. Presidential Advisory Council on Combating Antibiotic-resistant Bacteria. National Action 
Plan for Combating Antibotic-Resistant Bacteria. White House; 2015:1-63. 
2. Kroening-Roche JC, Soroudi A, Castillo EM, Vilke GM. Antibiotic and Bronchodilator 
Prescribing for Acute Bronchitis in the Emergency Department. J Emerg Med 2012; 43(2):221-
7. 
3. Gonzales R, Camargo CA, MacKenzie T, et al. Antibiotic treatment of acute respiratory 
infections in acute care settings. Acad Emerg Med 2006; 13: 288-94. 
4. Ozkaya E, Cambaz N, Coskun Y, et al. The Effect of Rapid Diagnostic Testing for Influenza 
on the Reduction of Antibiotic Use in Paediatric Emergency Department. Acta Paediatr 
2009;98(10): 1589-92. 
5. Centers for Disease Control and Prevention. FastStats: Emergency Department Visits. 
(Accessed October 30, 2015, at http://www.cdc.gov/nchs/fastats/emergency-department.htm.) 
6. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial 
stewardship in critical care: a systematic review. J Antimicrob Chemother 2011;66(6):1223-
1230. 
7. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the 
evidence base and case studies. Clin Infect Dis 2011;53:S23-28. 
8. Drekonja D, Filice G, Greer N, et al. Antimicrobial Stewardship Programs in Outpatient 
Settings: a Systematic Review. Washington (DC): Department of Veterans Affairs; 2014. 
9. Mistry R, Newland JG, Gerber JS, Hersch AL, May L, Perman SM, Kuppermann N. The state 
of antimicrobial stewardship in children’s hospitals. Presented at PAS, May 2016. 
10. Chisholm CD, Collison EK, Nelson DR, and Cordell WH. Emergency Department Workplace 
Interruptions Are Emergency Physicians “Interrupt-driven” and “Multitasking”?. Acad Emerg 
Med 2000; 7(11): 1239-43. 
11. Schafermeyer RW, Asplin BR. Hospital and emergency department crowding in the United 
States. Emerg Med (Fremantle) 2003;15(1):22-7. 
12. Delgado MK, Acosta CD, Ginde AA, et al. National survey of preventive health services in US 
emergency departments. Ann Emerg Med 2011;57(2):104-108.e2. 
13. Bernstein SL, Bernstein E, Boudreaux ED, et al. Public health considerations in knowledge 
translation in the emergency department. Acad Emerg Med 2007;14(11):1036-41.  
14. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice 
guidelines? JAMA 1999;282(15):1458. 
15. May L, Gudger G, Armstrong P, et al. Multisite exploration of clinical decision making for 
antibiotic use by emergency medicine providers using quantitative and qualitative methods. 
Infect Control Hosp Epidemiol 2014;35(9):1114-1125. 
16. Linder JA, Doctor JN, Friedberg MW, Reyes Nieva H, Birks C, Meeker D, Fox CR. Time of 
day and the decision to prescribe antibiotics. JAMA Intern Med 2014;174(12):2029-31. 
17. Thaler RH, Sunstein CR (2008). Nudge: Improving Decisions About Health, Wealth, and 
Happiness, Yale University Press. 
18. Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, Knight TK, Hay JW, 
Doctor JN. Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among 
Primary Care Practices: A Randomized Clinical Trial. JAMA. 2016;315(6):562-70. 
19. Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core Elements of Outpatient 
Antibiotic Stewardship. MMWR Recomm Rep. 2016 Nov 11;65(6):1-12. 
  
 
 
 
  29 MITIGATE Antimicrobial Stewardship Toolkit  
 
 Appendix 
Interview Structured Questions and Vignette (Physicians) 
1. You are here because you work in emergency medicine or urgent care and make antibiotic prescribing 
decisions for patients presenting with respiratory complaints. Please give a brief overview of your role in 
the department. 
Participants will read the ADULT or PEDS vignette 
2. Let’s talk about the work flow you would expect for this patient. 
a. What would the usual wait time for this patient be?  
b. What is the triage process for this patient?  
c. What would be your assessment process? 
d. What is the discharge process? 
3. How do you use the EHR in this process? (Probe for type, fit in workflow, eprescribing, order sets if they 
don’t come up.)  
4. Tell me about how you would talk to the patient about antibiotic use in this case?  
a. Would this be different based on patient expectation about antibiotics? How would this be 
assessed 
b. Probe for any education to patients about antibiotic use 
5. What is the general culture around antibiotic stewardship in your department? 
a. What are the barriers to antibiotic stewardship and patient education? 
b. What might facilitate antibiotic stewardship and patient education? 
6. Tell me about training you have received in any stewardship programs. In your opinion, what types of 
training and patient education works and what doesn’t? 
a. Discuss features of training in stewardship you sustained over time. 
b. Discuss features of training in stewardship you did not sustain over time. 
 
ADULT Vignette: 
A 27-year-old woman with no known underlying lung disease presents with a 10-day history of cough that is 
productive of yellow non bloody sputum. Her symptoms began with nasal congestion and a sore throat, but these 
initial symptoms resolved after a few days. Her remaining symptom is cough which is less productive than it was 
several days ago. She has some nasal congestion as well.  She denies any known sick contacts. Her cough does not 
occur in long fits, and she is not short of breath. On physical examination she is not in respiratory distress, afebrile, 
and has normal vital signs. Lung exam is normal. 
PEDIATRIC Vignette: 
A 2 year old male with no known underlying lung disease presents with a 4-day history of cough and intermittent 
fever with max Temp of 101. Child is in daycare with multiple sick contacts and is fully immunized.  On physical 
examination child is afebrile, there is clear rhinorrhea, both TMs are red but not bulging, and vital signs are 
otherwise normal. Lung exam reveals scattered expiratory wheezes. 
 How would you manage this patient/these patients? 
 Would you consider antibiotics for this patient? Under what circumstance? 
 What instructions would you give the patient or parent? 
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 What discussions would you anticipate around antibiotic use? 
ADULT 
OTC medications grouped: 
Of the drug choices below, please indicate which drugs 
you would choose in treating this patient. You may 
select up to three options.   
Prescription medications: 
 Albuterol inhaler 
 An antibiotic of your choice 
 Robitussin with codeine 
 Benzonatate 
Over-the-counter drugs: 
 Cough lozenge  
 Cough spray 
 Cough syrup 
OTC medications listed individually: 
Of the drug choices below, please indicate which drugs 
you would choose in treating this patient. You may 
select up to three options.   
Over-the-counter drugs: 
 Cough lozenge 
 Cough spray 
 Cough syrup 
Prescription drugs: 
 Albuterol inhaler 
 An antibiotic of your choice 
 Robitussin with codeine 
 Benzonatate 
PEDS 
OTC medications grouped: 
Of the drug choices below, please indicate which drugs 
you would choose in treating this patient. You may 
select up to three options.   
Prescription medications: 
 Albuterol inhaler 
 An antibiotic of your choice 
 Robitussin with codeine 
 Benzonatate 
Over-the-counter drugs: 
 Cough lozenge  
 Cough spray 
 Cough syrup 
OTC medications listed individually: 
Of the drug choices below, please indicate which drugs 
you would choose in treating this patient. You may 
select up to three options.   
Over-the-counter drugs: 
 Cough lozenge 
 Cough spray 
 Cough syrup 
Prescription medications: 
 Albuterol inhaler 
 An antibiotic of your choice 
 Robitussin with codeine 
 Benzonatate 
 
Structured Interview Questions and Vignette (Nurse) 
1. You are here because you work in emergency medicine and you or your team has a role in antibiotic 
prescription for patients coming into your department. Please give a brief overview of your role in the 
department. 
Participants will read the ADULT or PEDS vignette 
2. Let’s talk about the work flow you would expect for this patient. 
a. What would the usual wait time for this patient be?  
b. What is the triage process for this patient?  
c. How would this patient move through the department? Who would talk with the patient? 
d. What is the discharge process? 
3. How does the team use the EHR in this process? (Probe for type, fit in workflow, eprescribing, order sets if 
they don’t come up.)  
4. Tell me about how the team would handle antibiotic prescription for this patient?  
a. Would this be different based on patient beliefs about antibiotics? 
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b. Probe for any education to patients about antibiotic use 
c. What is the nursing role in patient education at triage and/or discharge for antibiotic use? 
5. What is the general culture around antibiotic stewardship in your department? 
a. What are the barriers to antibiotic stewardship and patient education? 
b. What might facilitate antibiotic stewardship and patient education? 
6. Tell me about training you have received in any stewardship programs. In your opinion, what types of 
training and patient education works and what doesn’t? 
a. Discuss features of training in stewardship you sustained over time. 
b. Discuss features of training in stewardship you did not sustain over time. 
 
ADULT Vignette: 
A 27-year-old woman with no known underlying lung disease presents with a 10-day history of cough that is 
productive of yellow non bloody sputum. Her symptoms began with nasal congestion and a sore throat, but these 
initial symptoms resolved after a few days. Her remaining symptom is cough which is less productive than it was 
several days ago. She has some nasal congestion as well.  She denies any known sick contacts. Her cough does not 
occur in long fits, and she is not short of breath. On physical examination she is not in respiratory distress, afebrile, 
and has normal vital signs. Lung exam is normal. 
PEDIATRIC Vignette: 
A 2 year old male with no known underlying lung disease presents with a 4-day history of cough and intermittent 
fever with max Temp of 101. Child is in daycare with multiple sick contacts and is fully immunized.  On physical 
examination child is afebrile, there is clear rhinorrhea, both TMs are red but not bulging, and vital signs are 
otherwise normal. Lung exam reveals scattered expiratory wheezes. 
 Would you consider antibiotics appropriate treatment for this patient? Under what circumstance? 
 What instructions would you give the patient or parent? 
 What discussions would you anticipate around antibiotic use? Describe typical education at discharge 
 
 
 
Structured Interview Questions and Vignette (Administrator) 
1. You are here because you work in emergency medicine and you or your team has a role in antibiotic 
prescription for patients coming into your department. Please give a brief overview of your role in the 
department. 
Participants will read the ADULT or PEDS vignette 
2. Let’s talk about the work flow you would expect for this patient. 
a. What would the usual wait time for this patient be?  
b. What is the triage process for this patient?  
c. How would this patient move through the department? Who would talk with the patient? 
d. What is the discharge process? 
e. What is the oversight or regulatory process? 
3. How does the team use the EHR in this process? (Probe for type, fit in workflow, eprescribing, order sets if 
they don’t come up.)  
4. Tell me about how the team would handle antibiotic prescription for this patient?  
a. Would this be different based on patient beliefs about antibiotics? 
b. Probe for any education to patients about antibiotic use 
c. What quality metrics might apply to this visit 
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 d. What support would be available to providers during this encounter to support clinical decision 
making? 
5. What is the general culture around antibiotic stewardship in your department? 
a. What are the barriers to antibiotic stewardship and patient education? 
b. What might facilitate antibiotic stewardship and patient education? 
c. What quality measures are currently being monitored? 
6. Tell me about training you have received in any stewardship programs. In your opinion, what types of 
training and patient education works and what doesn’t? 
a. Discuss features of training in stewardship you sustained over time. 
b. Discuss features of training in stewardship you did not sustain over time. 
 
 
 
ADULT Vignette: 
A 27-year-old woman with no known underlying lung disease presents with a 10-day history of cough that is 
productive of yellow non bloody sputum. Her symptoms began with nasal congestion and a sore throat, but 
these initial symptoms resolved after a few days. Her remaining symptom is cough which is less productive 
than it was several days ago. She has some nasal congestion as well.  She denies any known sick contacts. Her 
cough does not occur in long fits, and she is not short of breath. On physical examination she is not in 
respiratory distress, afebrile, and has normal vital signs. Lung exam is normal. 
PEDIATRIC Vignette: 
A 2 year old male with no known underlying lung disease presents with a 4-day history of cough and 
intermittent fever with max Temp of 101. Child is in daycare with multiple sick contacts and is fully immunized.  
On physical examination child is afebrile, there is clear rhinorrhea, both TMs are red but not bulging, and vital 
signs are otherwise normal. Lung exam reveals scattered expiratory wheezes. 
 What expectations or discussions would you anticipate with this scenario? 
 What types of educational materials or other resources might be available in these discussions 
 If the patient or parent leaves without an antibiotic Rx and is upset:   
 What are barriers to patient-provider communication? 
 What if the patient or parent files a complaint? 
Antimicrobial Stewardship Pre-Implementation Provider Survey 
The following are considered acute upper respiratory infections: the common cold, viral pharyngitis, acute 
bronchitis, bronchiolitis, croup, laryngitis, acute sinusitis, and acute otitis media. 
Practice: 
1. How frequently do you prescribe antibiotics to patients with acute bronchitis?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
2. How frequently do you prescribe antibiotics to patients with acute bronchiolitis?  
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a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
 
 
 
 
 
 
 
3. How frequently do you prescribe antibiotics to patients with laryngitis? 
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
4. How frequently do you prescribe antibiotics to patients with croup?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
5. How frequently do you prescribe antibiotics to patients with acute sinusitis?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
6. How frequently do you prescribe antibiotics to patients with acute otitis media?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
7. How frequently do you empirically prescribe antibiotics to patients with pharyngitis (without testing for 
group A strep)?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
8. How frequently do you think other clinicians in your practice prescribe antibiotics for the treatment of 
non-specific URIs? 
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
9. In some online studies, a small number of participants do not pay close attention to all of the items they 
are answering. To indicate that you are paying close attention, please do not mark any of the choices for 
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the following question: How frequently do you think physicians prescribe decongestants for non-specific 
URIs? 
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
 
 
 
 
 
 
 
10. Does your emergency department or urgent care center provide guidelines for prescribing antibiotics for 
acute respiratory infections?  
a. Yes, Please specify _______________________________________ 
b. No 
c. I don’t know 
11. Under what clinical conditions would you consider prescribing antibiotics that are non-adherent to 
professional society practice guidelines?  
Comments: 
12. Which guidelines/resources do you use to make decisions for prescribing antibiotics? 
a. Infectious Diseases Society of America (IDSA)  
b. American Academy of Pediatrics 
c. Centers for Disease Control and Prevention 
d. Up to Date 
e. Podcasts (e.g. EMRAP) 
f. Local or institutional guidelines 
g. Other, Please specify _______________________________________ 
13. In your opinion, what are current barriers to appropriate prescribing for acute respiratory infection? Check 
all that apply. 
  Lack of access to guidelines or information on prescribing 
  Lack of clear evidence and evidence-based recommendations 
  Patient expectations 
  Psychosocial barriers 
  Electronic Health Record  
  Other, Please specify _______________________________________ 
14. How often do you consult with other colleagues before prescribing antibiotics for acute upper respiratory 
infections?  
a. <10% of the time 
b. 10-25% of the time 
c. 26-50% of the time 
d. 51-75% of the time 
e. More than 75% of the time 
15. To the best of your knowledge, which of the following resources for outpatient antibiotic prescribing are 
currently present in your emergency department? Check all that apply. 
a. Pharmacist  
b. Direct physician feedback for antibiotic prescribing  
c. Formulary restriction/Required antibiotic approval by Infectious Disease (for any antibiotics)  
d. Published hospital-wide antibiogram (accessible via web, intranet or in print)  
e. Other, Please specify _______________________________________ 
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f. I do not know  
 
 
 
 
 
Attitudes:  
16. Antibiotic resistance is a public health problem facing the United States.  
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
17. Inappropriate antibiotic use contributes to antimicrobial resistance. 
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
18. To what extent do you feel antibiotics are over or underused for acute infections with 1 being very 
underused and 10 being very overused?  
1    2    3    4    5    6    7    8    9 
Frequently underused                                                                 Frequently overused 
19. For which conditions are antibiotics most frequently over-prescribed (either inappropriate use or overly 
broad spectrum use)? Check all that apply. 
a. Common cold 
b. Sinusitis 
c. Otitis media 
d. Pharyngitis 
e. Influenza 
f. Acute bronchitis 
g. Bronchiolitis 
h. Asthma 
i. Skin and Soft Tissue 
j. Gastrointestinal Infection 
k. Urinary tract infection 
l. NONE 
m. Other 
Comments: 
20. For which conditions are antibiotics most frequently under-prescribed (either inappropriate use or overly 
narrow spectrum use)? Check all that apply. 
a. Common cold 
b. Sinusitis 
c. Otitis media 
d. Pharyngitis 
e. Influenza 
f. Acute bronchitis 
g. Bronchiolitis 
h. Asthma 
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 i. Skin and Soft Tissue 
j. Gastrointestinal Infection 
k. Urinary tract infection 
l. NONE 
m. Other 
 
 
 
 
 
 
Comments: 
21. Antibiotic Stewardship programs are important to optimize antibiotic use in the ED and urgent care.  
a. Strongly Agree 
b. Agree 
c. Neutral  
d. Disagree 
e. Strongly Disagree 
22. ED and urgent care patients receive adequate education about the use and duration of antibiotic 
prescriptions prior to discharge. 
a. Strongly Agree 
b. Agree 
c. Neutral  
d. Disagree 
e. Strongly Disagree 
23. What resources do you use to stay up-to-date on current approaches to antibiotic prescribing? 
a. Departmental lectures/CME 
b. Web-based resources (Up to Date or other) 
c. Smart phone App or pocket guide (EMRA, Sanford Guide) 
d. Other lectures  
e. Other, Please specify _______________________________________ 
24.  ED and urgent care based antibiotic stewardship programs would interfere with my usual approach to 
clinical decision-making in treatment of infectious diseases.   
a. Strongly agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
If yes, why: __________________________________________ 
25. In your opinion, what are the best strategies to decrease inappropriate use of antibiotics? Check all that 
apply. 
  Better education in pre-clinical training (medical/nursing school)  
  Better education in residency training 
  Developing rigorous practice guidelines for empiric antibiotic treatment of common infections 
  Developing more order sets or decision support tools for the ED or urgent care 
  Other, Please specify _______________________________________ 
26. Based on your preference, please rank, in order (1 being the most preferable), the following methods to 
implement antimicrobial stewardship for the emergency department or urgent care? 
___ Provider continuing education 
___ Published institutional or local guidelines 
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___ Point-of-care clinical decision support via the electronic health record 
___ Individual feedback clinicians  
___ Other, Please specify _______________________________________ 
If you have any comments about ED or urgent care based antimicrobial stewardship, please provide them below: 
Demographics: 
27. Gender 
a. Male 
b. Female 
 
 
 
 
 
 
 
 
28. What is your clinical role within your hospital ED or urgent care?  
a. Attending physician  
b. Fellow physician  
c. Resident physician  
d. Nurse practitioner  
e. Physician assistant  
f. Other, Please specify _______________________________________ 
29. For how many years have you worked in this position? _____________ 
30. Proportion of pediatric patient’s ages 0-17 seen? 
  100% 
  >75% 
  50-74 
  26-49 
  11-25 
  <10 
31. What is your training? Check all that apply. 
  Internal medicine 
  Emergency medicine 
  Pediatrics 
  Pediatric emergency medicine 
  Specialized residency  
  Other, Please specify _______________________________________ 
32. Board Certified? Y/N  
33. Board Eligible? Y/N 
34. How long have you been practicing as an independent provider (since completion of training)?  
  ___________ months or years 
Antimicrobial Stewardship Post-Implementation Provider Survey 
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Attitudes: 
1. Antibiotic resistance is a public health problem facing the United States.  
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
 
 
 
 
 
2. Inappropriate antibiotic use contributes to antimicrobial resistance. 
a. Strongly Agree 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
3. Do you feel antibiotics are overused or underused in your emergency department or urgent care center 
with 1 being very underused and 10 being very overused?  
1  2   3    4    5    6    7    8    9         10 
Frequently underused                                                                                   Frequently overused 
4. For which conditions are antibiotics most frequently over-prescribed (either inappropriate use or overly 
broad spectrum use)? Check all that apply. 
a. Common cold 
b. Sinusitis 
c. Otitis media 
d. Pharyngitis 
e. Influenza 
f. Acute bronchitis 
g. Bronchiolitis 
h. Asthma 
i. Skin and Soft Tissue 
j. Gastrointestinal Infection 
k. Urinary tract infection 
l. NONE 
m. Other 
Comments: 
5. For which conditions are antibiotics most frequently under-prescribed (either inappropriate use or overly 
narrow spectrum use)? Check all that apply. 
a. Common cold 
b. Sinusitis 
c. Otitis media 
d. Pharyngitis 
e. Influenza 
f. Acute bronchitis 
g. Bronchiolitis 
h. Asthma 
i. Skin and Soft Tissue 
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j. Gastrointestinal Infection 
k. Urinary tract infection 
l. NONE 
m. Other 
 
 
 
 
 
 
 
 
Comments: 
6. Antibiotic Stewardship programs are important to optimize antibiotic use in the ED and urgent care.  
a. Strongly Agree 
b. Agree 
c. Neutral  
d. Disagree 
e. Strongly Disagree 
7. ED and urgent care patients receive adequate education about the use and duration of antibiotic 
prescriptions prior to discharge. 
a. Strongly Agree 
b. Agree 
c. Neutral  
d. Disagree 
e. Strongly Disagree 
8. What resources do you use to stay up-to-date on current approaches to antibiotic prescribing? 
a. Departmental lectures/CME 
b. Web-based resources (Up to Date or other) 
c. Smart phone App or pocket guide (EMRA, Sanford Guide) 
d. Other lectures  
e. Other, Please specify _______________________________________ 
ED/Urgent Care Stewardship Experience: 
9. Did you take part in the ED or urgent care stewardship program for acute respiratory infections?  
a. Basic intervention (education materials) 
b. Enhanced intervention (individual audit and feedback, peer to peer comparisons) 
c. I don’t know  
10. Which components of our stewardship intervention did you receive? 
a. Educational presentations at Academic Forum or other venues 
b. Distribution of clinical practice guidelines in person  
c. Distribution of clinical practice guidelines electronically 
d. Emails from stewardship program 
e. Departmental feedback on overall prescribing 
f. Individualized audit and feedback on your practice patterns 
g. I don’t know  
11. Did you participate in the individual audit/feedback portion of the ED or urgent care stewardship 
program?  
a. Yes  
b. No 
c. I don’t know  
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Please answer the following three questions if you participated in the audit and feedback portion of the 
program. 
 
 
 
 
 
 
12. Did you find it the audit and feedback portion of the program: 
a. Very useful  
b. Mostly useful 
c. Somewhat useful  
d. Marginally useful 
e. Not at all useful 
13. How bothersome was the audit and feedback? 
a. Extremely intrusive 
b. Very intrusive 
c. Somewhat intrusive 
d. A little intrusive 
e. Not at all intrusive 
14. How willing were you to change your practices based on the audit and feedback, with 1 being unwilling 
and 10 being very willing? 
  1   2    3     4      5        6       7       8        9            10 
Unwilling                                            Very willing  
 
15. Do you believe that ED and urgent care based antibiotic stewardship programs would interfere with my 
usual approach to clinical decision-making in treatment of infectious diseases.   
a. Strongly agree If yes, why:__________________________________________ 
b. Agree 
c. Neutral 
d. Disagree 
e. Strongly Disagree 
16. In your opinion, what are the best strategies to decrease inappropriate use of antibiotics? Check all that 
apply. 
  Better education in pre-clinical training (medical/nursing school)  
  Better education in residency training 
  Developing rigorous practice guidelines for empiric antibiotic treatment of common infections 
  Developing more order sets or decision support tools for the ED or urgent care 
  Other, Please specify _______________________________________ 
17. Based on your preference, please rank, in order (1 being the most preferable), the following methods to 
implement antimicrobial stewardship for the emergency department or urgent care? 
___ Provider continuing education 
___ Published institutional or local guidelines 
___ Point-of-care clinical decision support via the electronic health record 
___ Individual feedback clinicians  
___ Other, Please specify _______________________________________ 
18. What barriers do you see in appropriate prescribing for acute respiratory infections? 
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a. Lack of access to guidelines or information on prescribing 
b. Patient expectation 
c. Psychosocial barriers 
d. EHR  
e. Other, please specify 
Why? 
19. What are your personal feelings about the emergency department or urgent care stewardship 
program/intervention?  
a. Very helpful  
b. Slightly helpful  
c. Neutral  
d. Wasn’t helpful at all  
e. Other:_______________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20.  What additional resources would you like to see available as part of an ED or urgent care stewardship 
program and why? 
21. Has taking part in the stewardship intervention changed or improved your clinical practices?  
a. Yes. 
Please explain _______________________________________ 
b. No. 
Please explain _______________________________________ 
22. In what ways do you think we could better present the information to clinicians?  
Please explain _______________________________________ 
23. If you have any additional comments about ED-based antimicrobial stewardship, please provide them 
below: 
If you are interested sharing more information about your experience please contact us at: XXX 
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Additional Materials for Selection for Patient and Clinician Education 
California Medical Association Foundation AWARE 
program: 
Background & History: The Alliance Working for Antibiotic 
Resistance Education (AWARE) was initiated by the CMA 
Foundation in 2000, as a long-term statewide effort to promote 
the appropriate use of antibiotics.  Physician organizations, healthcare providers, health systems, health 
plans, public health agencies, consumer and community based organizations, federal, state and local 
government representatives and the pharmaceutical industry have all worked to achieve the mission and 
goals of this project. 
PROJECT MISSION 
• Reduce the unnecessary use of antibiotics and reduce the prevalence of antibiotic resistant bacteria 
in California. 
PROJECT GOALS 
• Increase appropriate prescribing of antibiotics.  
• Raise consumer awareness and understanding regarding the appropriate use of antibiotics. 
• Mobilize the community to reduce the unnecessary use of antibiotics 
Methods: The AWARE program uses numerous methods to reduce unnecessary antibiotic use. Each year 
an expert clinical work group meets to develop timely educational materials regarding appropriate 
antibiotic use for adult and pediatric care.  These tools, known as the AWARE Toolkit, are available in 
English and Spanish. The CMA Foundation mails these Toolkit materials to high-prescribing physicians to 
promote adherence to appropriate prescribing guidelines. The full version of the AWARE Toolkit is 
available for free under Resources and an abbreviated version is available on the iTunes App Store and on 
Google Play.  
Physician Resources: http://www.thecmafoundation.org/Resources/Physician-Resources 
 
AWARE Compendia Application Toolkit 
The Adult compendia summarize the treatment and prescribing guidelines from leading medical experts 
and professional organizations in the United States for: 
• Acute Bacterial Sinusitis 
• Pharyngitis 
• Nonspecific Cough Illness/Acute Bronchitis/COPD 
• Pertussis 
• Nonspecific URI 
• Outpatient Community-Acquired Pneumonia (CAP) 
• Skin and Soft Tissue Infection 
• Urinary Tract Infection 
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The Pediatric compendia summarize the treatment and prescribing guidelines from leading medical 
experts and professional organizations in the United States for: 
• Acute Bacterial Sinusitis 
• Pharyngitis 
• Nonspecific Cough Illness/ Bronchitis/ Pertussis 
• Bronchiolitis/ Nonspecific URI 
• Otitis Media 
• Skin and Soft Tissue Infection 
• Urinary Tract Infection 
 
If you are interested in receiving a printed copy of the AWARE Toolkit please contact CMA Foundation 
at (916)779-6620 or at Admin@thecmafoundation.org. 
Additional Patient Resources:  
English - http://www.thecmafoundation.org/Resources/Patient-Resources 
Spanish - http://www.thecmafoundation.org/Resources/-Recursos-para-Pacientes 
 
More information can be found at: http://www.thecmafoundation.org/Programs/AWARE 
Educational Presentations for Clinicians:  Please contact Larissa May at lsmay@ucdavis.edu 
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Assessment steps 
STEP 1: Identify Appropriate Staff: 
 Program Champion(s):  
 Key Administrators:  
 IT support:  
 Key Stakeholders:  
 Nursing staff:  
 
STEP 2: Pre-Implementation Stakeholder Interviews: 
 Who will conduct interviews: _____________________________________ 
 Prepare a wide range of sample materials 
o https://www.cdc.gov/antibiotic-use/ 
o http://www.thecmafoundation.org/Programs/AWARE 
 Take comprehensive notes  
STEP 3: Pre-Implementation Surveys: 
 Create using:  
o REDCap  
o Qualtrics  
o Survey Monkey 
 Target date to send survey: 
 Person responsible for sending surveys 
 Target date for survey completion 
 Compile data 
STEP 4: Launching the Program: 
 Hold presentations / educational sessions  
 Send out announcement email to all staff 
 Pick your date(s): ____________________________ 
STEP 5: Analyze and Report Key Findings to Program: 
 Stakeholder demographics 
 Baseline attitudes towards antibiotic prescribing 
 Knowledge of antibiotic use and guidelines 
 Preferences regarding commitment tools 
 Preferences regarding patient and clinician educational tools 
 Identified gaps 
  45 MITIGATE Antimicrobial Stewardship Toolkit  
 
 
Action steps 
STEP 1. Choose Materials: 
o Posters 
o Educational Videos 
o Info Graphics 
o Smartphone app 
o Pamphlets  
o Flyers 
o Electronic Health Record education 
o Social media messaging 
o Viral Prescription pad. 
 Materials ordered: _________________________ 
Will you participate in antibiotics awareness week? 
 Yes 
 No 
 At a future date 
 
STEP 2: Choose Nudges: 
o Potential nudge options 
 Materials ordered: _________________________ 
 Public Commitment 
o Potential flair options  
 Badge Reel 
 Pin 
 Other: _________________________ 
 
STEP 3: Share Your Knowledge 
 Choose placement / use of materials 
 Describe plan:  
 
STEP 4: Data Gathering 
 Choose feedback methods: 
 Department 
 Individual Physician 
 Peer comparison report 
• Frequency:  Monthly vs. Other 
o IT Contact for data extraction: 
____________________________________________ 
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STEP 5: Data Share 
Launch Date:__________________________________________ 
How will launch be communicated to team: 
___________________________________ 
First feedback send date: __________________________________________ 
Follow up assessment date(s): 
o 3 months 
o 6 months 
o 12 months 
o Other 
STEP 6: Outcomes and Sustainability 
 Pre and Post Survey Results on Knowledge, Attitudes, Beliefs 
 Ongoing Prescribing Data Compared to Baseline 
o SPC charts 
o Graphical Display 
 Clinician Experience with Program 
 Institutional Buy-in For Sustainability 
o Data Reports 
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